This company has been marked as potentially delisted and may not be actively trading. Imunon (CLSN) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Imunon Short Interest DataImunon (CLSN) has a short interest of 55,900 shares, representing 0.79% of the float (the number of shares available for trading by the public). This marks a -35.60% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 150,471 shares to cover all short positions.Current Short Interest55,900 sharesPrevious Short Interest86,800 sharesChange Vs. Previous Month-35.60%Dollar Volume Sold Short$119.07 thousandShort Interest Ratio0.8 Days to CoverLast Record DateAugust 31, 2022Outstanding Shares7,099,000 sharesFloat Size7,060,000 sharesShort Percent of Float0.79%Today's Trading Volume711 sharesAverage Trading Volume150,471 sharesToday's Volume Vs. Average0% Short Selling Imunon? Sign up to receive the latest short interest report for Imunon and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLSN Short Interest Over TimeCLSN Days to Cover Over TimeCLSN Percentage of Float Shorted Over Time Imunon Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/202255,900 shares $119.07 thousand -35.6%0.8%0.8 $2.13 8/15/202286,800 shares $220.47 thousand +3.3%1.2%1.3 $2.54 7/31/202284,000 shares $183.12 thousand -12.0%1.2%1.3 $2.18 7/15/202295,400 shares $190.80 thousand -15.0%1.4%1.5 $2.00 6/30/2022112,200 shares $206.45 thousand -11.2%1.6%0.8 $1.84 6/15/2022126,300 shares $246.29 thousand -8.1%1.8%0.4 $1.95 5/31/2022137,400 shares $335.26 thousand No Change2.0%0.4 $2.44 5/15/2022137,400 shares $350.37 thousand -22.8%2.0%0.4 $2.55 4/30/2022177,900 shares $515.91 thousand -8.9%2.5%0.6 $2.90 4/15/2022195,300 shares $683.55 thousand +236.1%2.8%0.6 $3.50 Get the Latest News and Ratings for CLSN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Imunon and its competitors with MarketBeat's FREE daily newsletter. 3/31/202258,100 shares $293.99 thousand -50.3%1.0%0.2 $5.06 3/15/2022116,800 shares $572.32 thousand +100.3%2.0%2.2 $4.90 2/28/202258,300 shares $282.99 thousand -94.3%1.0%1.1 $4.85 2/15/20221,020,000 shares $421.67 thousand +7.0%N/A1.6 $0.41 1/31/2022953,000 shares $452.68 thousand -4.1%N/A1.3 $0.48 1/15/2022993,900 shares $461.77 thousand -15.1%N/A1.3 $0.46 12/31/20211,170,000 shares $631.80 thousand +3.5%N/A1.5 $0.54 12/15/20211,130,000 shares $728.85 thousand +3.7%N/A1.5 $0.65 11/30/20211,090,000 shares $838.43 thousand -36.6%N/A1.2 $0.77 11/15/20211,720,000 shares $1.46 million -27.1%N/A1.8 $0.85 10/29/20212,360,000 shares $2.14 million +3.1%N/A2.5 $0.91 10/15/20212,290,000 shares $2.29 million +39.6%N/A2.2 $1.00 9/30/20211,640,000 shares $1.52 million -4.1%N/A1.6 $0.92 9/15/20211,710,000 shares $1.76 million -1.7%N/A1.6 $1.03 8/31/20211,740,000 shares $1.84 million -8.4%N/A1.3 $1.06 8/13/20211,900,000 shares $1.98 million -0.5%N/A1.3 $1.04 7/30/20211,910,000 shares $2.12 million -1.0%N/A1.3 $1.11 7/15/20211,930,000 shares $2.08 million +1.6%N/A1.3 $1.08 6/30/20211,900,000 shares $2.41 million +19.5%N/A1 $1.27 6/15/20211,590,000 shares $2.08 million -9.7%N/A0.6 $1.31 5/28/20211,760,000 shares $2.08 million -2.8%N/A0.6 $1.18 5/14/20211,810,000 shares $1.79 million -11.3%2.1%0.4 $0.99 4/30/20212,040,000 shares $2.45 million -17.7%2.4%0.2 $1.20 4/15/20212,480,000 shares $3.10 million -28.3%3.0%0.2 $1.25 3/31/20213,460,000 shares $5.64 million -3.6%4.7%0.2 $1.63 3/15/20213,590,000 shares $7.97 million -3.2%6.0%0.2 $2.22 2/26/20213,710,000 shares $8.16 million +78.4%6.2%0.2 $2.20 2/12/20212,080,000 shares $4.76 million -5.5%3.4%0.1 $2.29 1/29/20212,200,000 shares $3.15 million +54.9%3.6%0.2 $1.43 1/15/20211,420,000 shares $1.28 million No Change2.4%0.2 $0.90Banks aren’t ready for this altcoin—are you? (Ad)I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.Discover our #1 crypto for the red-hot crypto market right now! CLSN Short Interest - Frequently Asked Questions What is Imunon's current short interest? Short interest is the volume of Imunon shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 55,900 shares of CLSN short. 0.79% of Imunon's shares are currently sold short. Learn More on Imunon's current short interest. What is a good short interest ratio for Imunon? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLSN shares currently have a short interest ratio of 1.0. Learn More on Imunon's short interest ratio. What is a good short interest percentage for Imunon? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.79% of Imunon's floating shares are currently sold short. Is Imunon's short interest increasing or decreasing? Imunon saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 55,900 shares, a decline of 35.6% from the previous total of 86,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Imunon's float size? Imunon currently has issued a total of 7,099,000 shares. Some of Imunon's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Imunon currently has a public float of 7,060,000 shares. How does Imunon's short interest compare to its competitors? 0.79% of Imunon's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Imunon: Actinium Pharmaceuticals, Inc. (4.88%), Aadi Bioscience, Inc. (6.58%), Marinus Pharmaceuticals, Inc. (3.95%), Allakos Inc. (0.37%), Eagle Pharmaceuticals, Inc. (0.46%), Cara Therapeutics, Inc. (1.74%), NanoViricides, Inc. (0.59%), 23andMe Holding Co. (11.90%), GlycoMimetics, Inc. (2.90%), Orgenesis Inc. (0.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Corporation ($4.91 billion), Charter Communications, Inc. ($3.53 billion), Suncor Energy Inc. ($2.26 billion), T. Rowe Price Group, Inc. ($2.01 billion), Chesapeake Energy Co. ($1.92 billion), Lucid Group, Inc. ($1.84 billion), Plug Power, Inc. ($1.81 billion), Williams-Sonoma, Inc. ($1.66 billion), Coinbase Global, Inc. ($1.64 billion), and Lumen Technologies, Inc. ($1.50 billion). View all of the most shorted stocks. What does it mean to sell short Imunon stock? Short selling CLSN is an investing strategy that aims to generate trading profit from Imunon as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Imunon? A short squeeze for Imunon occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLSN, which in turn drives the price of the stock up even further. How often is Imunon's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLSN, twice per month. The most recent reporting period available is August, 31 2022. More Short Interest Resources from MarketBeat Related Companies Actinium Pharmaceuticals Short Squeeze Aadi Bioscience Short Squeeze Marinus Pharmaceuticals Short Squeeze Allakos Short Squeeze Eagle Pharmaceuticals Short Squeeze Cara Therapeutics Short Squeeze NanoViricides Short Squeeze 23andMe Short Squeeze GlycoMimetics Short Squeeze Orgenesis Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLSN) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imunon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imunon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.